These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35261921)

  • 21. [Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension].
    Pose Reino A; González-Juanatey JR; Castroviejo M; Valdés L; Estévez JC; Méndez I; Cabezas-Cerrato J
    Med Clin (Barc); 1997 Mar; 108(8):281-5. PubMed ID: 9121203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular hypertrophy in hypertensive elderly patients with carvedilol.
    Verza M; Ammendola S; Cambardella A; Scoti G; Vescio S; Tortoriello R; Amato L; Cerqua G; Varricchio G
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():143-7. PubMed ID: 18653022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Left ventricular remodeling in association of arterial hypertension with diabetes mellitus type 2: correlation with gender and disease duration].
    Karpov RS; Koshel'skaia OA
    Ter Arkh; 2007; 79(1):32-8. PubMed ID: 17385461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
    Olsen MH; Wachtell K; Hermann KL; Frandsen E; Dige-Petersen H; Rokkedal J; Devereux RB; Ibsen H
    Am Heart J; 2002 Sep; 144(3):530-7. PubMed ID: 12228792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months.
    Gerdts E; Svarstad E; Aanderud S; Myking OL; Lund-Johansen P; Omvik P
    Am J Hypertens; 1998 Oct; 11(10):1178-87. PubMed ID: 9799034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
    Catena C; Verheyen ND; Url-Michitsch M; Kraigher-Krainer E; Colussi G; Pilz S; Tomaschitz A; Pieske B; Sechi LA
    Am J Hypertens; 2016 Mar; 29(3):303-10. PubMed ID: 26163660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
    Cheung BM; Lau CP
    Br J Clin Pharmacol; 1999 Feb; 47(2):179-87. PubMed ID: 10190653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy].
    Schmieder RE; Grube E; Impelmann V; Rüddel H; Schulte W
    Z Kardiol; 1990 Aug; 79(8):557-64. PubMed ID: 2145705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of left ventricular hypertrophy in patients with essential hypertension.
    Glasser SP; Koehn DK
    Clin Cardiol; 1989 Mar; 12(3):129-32. PubMed ID: 2522362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children.
    Jing L; Nevius CD; Friday CM; Suever JD; Pulenthiran A; Mejia-Spiegeler A; Kirchner HL; Cochran WJ; Wehner GJ; Chishti AS; Haggerty CM; Fornwalt BK
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):86. PubMed ID: 29117866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular structure and function in previously untreated hypertensive patients: the importance of blood pressure, the nocturnal blood pressure dip and heart rate.
    Mayet J; Shahi M; Hughes AD; Stanton AV; Poulter NR; Sever PS; Foale RA; Thom SA
    J Cardiovasc Risk; 1995 Jun; 2(3):255-61. PubMed ID: 7584802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of blood pressure in rest and exercise conditions and importance of clinical factors in left ventricular hypertrophy in arterial hypertension].
    Frimm CC; de Moraes AV; Medeiros C; Silva HB; Bellotti G; Krieger EM; Pileggi F
    Arq Bras Cardiol; 1994 Jul; 63(1):21-6. PubMed ID: 7857207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.
    Sumino H; Nakamura T; Kanda T; Sakamaki T; Sato K; Saito Y; Hoshino J; Kurashina T; Ono Z; Takahashi T; Ichikawa S; Kurabayashi M; Nagai R
    Jpn Heart J; 2000 May; 41(3):339-48. PubMed ID: 10987352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inadequate suppression of angiotensin II modulates left ventricular structure in humans.
    Schlaich MP; Schobel HP; Langenfeld MR; Hilgers K; Schmieder RE
    Clin Nephrol; 1998 Mar; 49(3):153-9. PubMed ID: 9543596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
    Gerdts E; Zabalgoitia M; Björnstad H; Svendsen TL; Devereux RB
    Am J Cardiol; 2001 Apr; 87(8):980-3; A4. PubMed ID: 11305990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.